Keyphrases
Age Groups
16%
Amputation
100%
Confounding Variables
16%
Cox Model
16%
Denmark
100%
Diabetes
16%
Diabetes Risk
100%
Diabetes Type 2
100%
Glucagon-like
100%
Hazard Ratio
16%
Liraglutide
16%
Lower Limb Amputation
16%
Medication Dosing
16%
Middle Income
16%
National Register
16%
Patient Comorbidities
16%
Risk Reduction
33%
Socioeconomic Factors
16%
Time-varying Model
16%
Treatment Experience
16%
Type 2 Diabetes Mellitus (T2DM)
16%
Type 2 Diabetic Patients
16%
Medicine and Dentistry
Amputation
100%
Cohort Analysis
100%
Diabetes
25%
Drug Therapy
25%
Glucagon Like Peptide 1
100%
Glucagon-Like Peptide-1 Agonist
50%
Hazard Ratio
25%
Leg Amputation
25%
Liraglutide
25%
Maturity Onset Diabetes of the Young
100%
Patient with Type 2 Diabetes
25%
Proportional Hazards Model
25%
Risk Reduction
25%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Comorbidity
25%
Glucagon Like Peptide 1 Receptor Agonist
50%
Glucagon-Like Peptide-1
100%
Liraglutide
25%
Non Insulin Dependent Diabetes Mellitus
100%
Mathematics
Confounding
100%
Hazard Ratio
100%
Proportional Hazards Model
100%